05/16/2025 7:18 AM | Windtree Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/15/2025 4:21 PM | Windtree Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/01/2025 7:33 AM | Windtree Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/30/2025 6:29 AM | Windtree Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/27/2025 11:15 PM | Windtree Therapeutics (Filer)
| Form EFFECT | |
04/24/2025 3:45 PM | Windtree Therapeutics (Filer)
| Form S-1/A | |
04/15/2025 4:20 PM | Windtree Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
04/15/2025 7:17 AM | Windtree Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/10/2025 4:03 PM | Windtree Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/31/2025 4:27 PM | Windtree Therapeutics (Filer)
| Form NT 10-K | |
03/25/2025 4:24 PM | Windtree Therapeutics (Filer)
| Form 8-K/A | |
Get the Latest News and Ratings for WINT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Windtree Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
03/24/2025 3:38 PM | Windtree Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/18/2025 7:10 AM | Windtree Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2025 4:20 PM | Windtree Therapeutics (Filer)
| Form 8-K/A | |
02/14/2025 3:44 PM | ARMISTICE CAPITAL, LLC (Filed by) Windtree Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/03/2025 4:20 PM | Windtree Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/27/2025 4:05 PM | Windtree Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/13/2025 7:09 AM | Windtree Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2025 3:25 PM | Windtree Therapeutics (Filer)
| Form DEF 14A | |
01/08/2025 7:05 AM | Windtree Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/30/2024 5:03 AM | Windtree Therapeutics (Filer)
| Form PRE 14A | |
12/05/2024 6:12 AM | Windtree Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/04/2024 7:02 AM | Windtree Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/27/2024 3:43 PM | Windtree Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/26/2024 3:46 PM | Windtree Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/15/2024 3:32 PM | Windtree Therapeutics (Filer)
| Form 8-K/A | |
11/15/2024 3:30 PM | Windtree Therapeutics (Filer)
| Form NT 10-Q | |
11/14/2024 6:15 PM | Lind Global Fund II LP (Filed by) Windtree Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024 7:53 AM | Flynn James E (Filed by) Windtree Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024 7:01 AM | Windtree Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/09/2024 6:46 AM | Fraser Craig (Reporting) Windtree Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2024 4:27 PM | Windtree Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/01/2024 4:28 PM | Windtree Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/01/2024 7:55 AM | Windtree Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/30/2024 7:22 AM | Windtree Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/25/2024 7:05 AM | Windtree Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/24/2024 4:21 PM | Windtree Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/13/2024 4:26 PM | Windtree Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/03/2024 11:15 PM | Windtree Therapeutics (Filer)
| Form EFFECT | |
09/03/2024 11:15 PM | Windtree Therapeutics (Filer)
| Form EFFECT | |
09/03/2024 8:09 AM | Windtree Therapeutics (Filer)
| Form 424B5 | |
A grave, grave error. (Ad) I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was.
Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.  Here’s the full story for you. |
09/03/2024 8:10 AM | Windtree Therapeutics (Filer)
| Form 424B5 | |
09/03/2024 6:26 AM | Windtree Therapeutics (Filer)
| Form ARS | |
09/03/2024 6:22 AM | Windtree Therapeutics (Filer)
| Form DEF 14A | |
08/23/2024 3:15 PM | Windtree Therapeutics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
08/21/2024 3:55 PM | Windtree Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
08/20/2024 7:44 PM | Windtree Therapeutics (Filer)
| Form PRE 14A | |
08/20/2024 3:30 PM | Windtree Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2024 3:24 PM | PELLETIER SAUNDRA L (Reporting) Windtree Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
07/29/2024 7:33 AM | Windtree Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/25/2024 3:07 PM | Windtree Therapeutics (Filer)
| Form RW | |
07/24/2024 4:27 PM | Fraser Craig (Reporting) Windtree Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/24/2024 4:28 PM | Simonson Steven (Reporting) Windtree Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/22/2024 8:25 AM | Windtree Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/10/2024 3:53 PM | Windtree Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/03/2024 8:11 AM | Windtree Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |